CDKN2A and neoplasm: Meeting these criteria, we observed hypermethylation of a CpG site located in the gene body of the tumor-suppressor gene CDKN2A in cluster 1 (DDLS) and cluster 3 (PLS) compared to both normal fat samples (CpG short name 3–07 in Additional file 2: Figure S7a, b).